A case of succinic semialdehyde dehydrogenase deficiency with status epilepticus and rapid regression
- 1 October 2016
- journal article
- research article
- Published by Elsevier in Brain and Development
- Vol. 38 (9) , 866-870
Abstract
No abstract availableKeywords
Funding Information
- Japan Agency for Medical Research and Development (049, H26-Nanji-Ippan-051)
- Lowy Medical Research Institute
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare (24-7, 27-5)
- Tokyo Medical and Dental University
- Takeda Science Foundation
- National Center of Neurology and Psychiatry
This publication has 10 references indexed in Scilit:
- Intravenous ketamine for the treatment of refractory status epilepticus: A retrospective multicenter studyEpilepsia, 2013
- Therapeutic Efficacy of Magnesium Valproate in Succinic Semialdehyde Dehydrogenase Deficiency2012
- Thirty years beyond discovery—Clinical trials in succinic semialdehyde dehydrogenase deficiency, a disorder of GABA metabolismJournal of Inherited Metabolic Disease, 2012
- A boy with a severe phenotype of succinic semialdehyde dehydrogenase deficiencyBrain and Development, 2012
- Epilepsy in succinic semialdehyde dehydrogenase deficiency, a disorder of GABA metabolismBrain and Development, 2011
- Succinic Semialdehyde Dehydrogenase: Biochemical–Molecular–Clinical Disease Mechanisms, Redox Regulation, and Functional SignificanceAntioxidants & Redox Signaling, 2011
- Decreased GABA-A binding on FMZ-PET in succinic semialdehyde dehydrogenase deficiencyNeurology, 2009
- Cerebral MRI abnormalities associated with vigabatrin therapyEpilepsia, 2009
- Effect of valproic acid on the urinary metabolic profile of a patient with succinic semialdehyde dehydrogenase deficiencyJournal of Chromatography B, 2003
- Neuroradiologic Findings in Focal Cortical Dysplasia: Histologic Correlation with Surgically Resected SpecimensEpilepsia, 2001